World Orphan Drug Congress 2018: the key to success is early engagement with all stakeholders
Earlier this month, Oxford PharmaGenesis was delighted to attend the 9th World Orphan Drug Congress (WODC) in Barcelona, Spain.
30 October 2025
Bold Ideas, Bright Futures: Brilliance in Medical Affairs was the theme of this year’s joint Medical Affairs Professionals of Australasia (MAPA) and Medical Affairs Professional Society (MAPS) Australasia Medical Affairs Summit. The 2-day meeting was held on 24 and 25 September in Sydney, Australia, and welcomed over 300 attendees and 75 faculty members.
Earlier this month, Oxford PharmaGenesis was delighted to attend the 9th World Orphan Drug Congress (WODC) in Barcelona, Spain.
Open Pharma reached the finals of the Community Partnership of the Year Award category at this year’s prestigious Scrip awards.
Members of the Oxford PharmaGenesis Patient Engagement team attended the 4th Annual Rare Disease Patient Network Meeting in Cardiff, UK, on Thursday 18 October, along with patients, carers and patient advocates.
HealthScience experts from the Oxford PharmaGenesis Patient Engagement team attended the 2018 Patient Summit Europe in London (16–17 October), which brought together pharma stakeholders, patients and patient advocates.
The Oxford PharmaGenesis team was proud to participate in and support ‘Surfing the Waves’, the inaugural West Coast meeting of the International Society for Medical Publication Professionals (ISMPP), which took place on 11–12 October 2018, in San Diego, CA, USA.
Last week, Oxford PharmaGenesis, the independent global HealthScience communications consultancy, ran a 2-day Mental Health First Aid (MHFA) course in partnership with the mental health charity Mind for 15 employees from our Oxford, Cardiff and London offices.